Tracy Wheeler

Mar 18, 2024 | newsroom.clevelandclinic.org | Tracy Wheeler

New Cleveland Clinic-led research provides evidence that video laryngoscopy significantly decreased the number of attempts needed to achieve intubation in adult surgical patients who required single-lumen endotracheal intubation for general anesthesia, compared with direct laryngoscopy. The research was published today in JAMA. Video laryngoscopy utilizes video camera technology to visualize airway structures and facilitate endotracheal intubation.

Mar 5, 2024 | newsroom.clevelandclinic.org | Tracy Wheeler

New Cleveland Clinic-led research points to sildenafil (Viagra) as a potential treatment for Alzheimer’s disease. The study provides evidence from computational models, insurance claims data and observations from brain cells in Alzheimer’s patients. Sildenafil is the main component of drugs used to treat erectile dysfunction (Viagra) and pulmonary arterial hypertension (Revatio).

Nov 27, 2023 | newsroom.clevelandclinic.org | Tracy Wheeler

Cleveland Clinic and Canon Inc. have announced intentions to form a strategic research partnership to develop innovative imaging and healthcare IT technologies aimed at improving diagnosis, care and outcomes for patients. The two organizations expect to establish a comprehensive imaging research center. The center will potentially include shared workspace in an existing building in Cleveland’s Fairfax neighborhood, adjacent to Cleveland Clinic’s main campus.

Nov 21, 2023 | newsroom.clevelandclinic.org | Tracy Wheeler

Cleveland Clinic is the first medical center in the United States to have performed a minimally invasive gastric sleeve procedure using a recently FDA-approved surgery robot with magnetic technology. Gastric sleeve surgery, also called sleeve gastrectomy, is one of the most common bariatric surgery procedures.

Nov 11, 2023 | newsroom.clevelandclinic.org | Tracy Wheeler

Findings from a multi-center, international clinical trial reported by a Cleveland Clinic physician show that semaglutide reduced cardiovascular events by 20% in adults with overweight or obesity and established cardiovascular disease who don’t have diabetes. Semaglutide is primarily prescribed for adults with type 2 diabetes but is also approved for chronic weight management in adults with obesity or overweight and have at least one other health issue.